ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Large Volume Parenteral (LVP) Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-0L5323
Home | Market Reports | Health| Pharmacy
Global Large Volume Parenteral LVP Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Large Volume Parenteral (LVP) Market Research Report 2024

Code: QYRE-Auto-0L5323
Report
January 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs

Large Volume Parenteral (LVP) Market Size

The global Large Volume Parenteral (LVP) market was valued at US$ 10530 million in 2023 and is anticipated to reach US$ 14000 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.

Large Volume Parenteral (LVP) Market

Large Volume Parenteral (LVP) Market

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).

Report Scope

The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Large Volume Parenteral (LVP) Market Report

Report Metric Details
Report Name Large Volume Parenteral (LVP) Market
Accounted market size in 2023 US$ 10530 million
Forecasted market size in 2030 US$ 14000 million
CAGR 4.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
Segment by Application
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Beximco Pharma, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Large Volume Parenteral (LVP) Market growing?

Ans: The Large Volume Parenteral (LVP) Market witnessing a CAGR of 4.1% during the forecast period 2024-2030.

What is the Large Volume Parenteral (LVP) Market size in 2030?

Ans: The Large Volume Parenteral (LVP) Market size in 2030 will be US$ 14000 million.

What is the market share of major companies in Large Volume Parenteral (LVP) Market?

Ans: The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market.

What is the Large Volume Parenteral (LVP) Market share by type?

Ans: In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%.

Who are the main players in the Large Volume Parenteral (LVP) Market report?

Ans: The main players in the Large Volume Parenteral (LVP) Market are Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Beximco Pharma, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs

What are the Application segmentation covered in the Large Volume Parenteral (LVP) Market report?

Ans: The Applications covered in the Large Volume Parenteral (LVP) Market report are Basic Infusion, Therapeutic Infusion, Nutritious Infusion

What are the Type segmentation covered in the Large Volume Parenteral (LVP) Market report?

Ans: The Types covered in the Large Volume Parenteral (LVP) Market report are Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP

1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024-2030)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Market Value by Application: (2024-2030)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2019-2030
1.4.2 Global Large Volume Parenteral (LVP) Sales 2019-2030
1.4.3 Global Large Volume Parenteral (LVP) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2019-2024)
2.4 Global Large Volume Parenteral (LVP) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
2.7 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.7.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.7.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Large Volume Parenteral (LVP) Global Large Volume Parenteral (LVP) Sales by Region: 2019-2030
3.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2019-2024
3.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2025-2030
3.3 Global Large Volume Parenteral (LVP) Global Large Volume Parenteral (LVP) Revenue by Region: 2019-2030
3.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2019-2024
3.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2025-2030
3.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type (2019-2030)
4.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2019-2024)
4.1.2 Global Large Volume Parenteral (LVP) Sales by Type (2025-2030)
4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2019-2030)
4.2 Global Large Volume Parenteral (LVP) Revenue by Type (2019-2030)
4.2.1 Global Large Volume Parenteral (LVP) Revenue by Type (2019-2024)
4.2.2 Global Large Volume Parenteral (LVP) Revenue by Type (2025-2030)
4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2019-2030)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Large Volume Parenteral (LVP) Sales by Application (2019-2030)
5.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2019-2024)
5.1.2 Global Large Volume Parenteral (LVP) Sales by Application (2025-2030)
5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2019-2030)
5.2 Global Large Volume Parenteral (LVP) Revenue by Application (2019-2030)
5.2.1 Global Large Volume Parenteral (LVP) Revenue by Application (2019-2024)
5.2.2 Global Large Volume Parenteral (LVP) Revenue by Application (2025-2030)
5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2019-2030)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Beximco Pharma
6.12.1 Beximco Pharma Corporation Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments/Updates
6.13 Albert David
6.13.1 Albert David Corporation Information
6.13.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments/Updates
6.14 PSI Ltd
6.14.1 PSI Ltd Corporation Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments/Updates
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Corporation Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments/Updates
6.16 BAG Healthcare
6.16.1 BAG Healthcare Corporation Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Corporation Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Parenteral (LVP) Industry Chain Analysis
7.2 Large Volume Parenteral (LVP) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Parenteral (LVP) Production Mode & Process
7.4 Large Volume Parenteral (LVP) Sales and Marketing
7.4.1 Large Volume Parenteral (LVP) Sales Channels
7.4.2 Large Volume Parenteral (LVP) Distributors
7.5 Large Volume Parenteral (LVP) Customers
8 Large Volume Parenteral (LVP) Market Dynamics
8.1 Large Volume Parenteral (LVP) Industry Trends
8.2 Large Volume Parenteral (LVP) Market Drivers
8.3 Large Volume Parenteral (LVP) Market Challenges
8.4 Large Volume Parenteral (LVP) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
List of Tables
    Table 1. Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Large Volume Parenteral (LVP) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Manufacturers (2019-2024)
    Table 5. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Large Volume Parenteral (LVP), Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
    Table 12. Global Key Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Large Volume Parenteral (LVP) Sales by Region (2019-2024) & (M Units)
    Table 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2019-2024)
    Table 19. Global Large Volume Parenteral (LVP) Sales by Region (2025-2030) & (M Units)
    Table 20. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2025-2030)
    Table 21. Global Large Volume Parenteral (LVP) Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2019-2024)
    Table 23. Global Large Volume Parenteral (LVP) Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2025-2030)
    Table 25. North America Large Volume Parenteral (LVP) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Large Volume Parenteral (LVP) Sales by Country (2019-2024) & (M Units)
    Table 27. North America Large Volume Parenteral (LVP) Sales by Country (2025-2030) & (M Units)
    Table 28. North America Large Volume Parenteral (LVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Large Volume Parenteral (LVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Large Volume Parenteral (LVP) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Large Volume Parenteral (LVP) Sales by Country (2019-2024) & (M Units)
    Table 32. Europe Large Volume Parenteral (LVP) Sales by Country (2025-2030) & (M Units)
    Table 33. Europe Large Volume Parenteral (LVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Large Volume Parenteral (LVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2019-2024) & (M Units)
    Table 37. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2025-2030) & (M Units)
    Table 38. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Large Volume Parenteral (LVP) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Large Volume Parenteral (LVP) Sales by Country (2019-2024) & (M Units)
    Table 42. Latin America Large Volume Parenteral (LVP) Sales by Country (2025-2030) & (M Units)
    Table 43. Latin America Large Volume Parenteral (LVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Large Volume Parenteral (LVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Large Volume Parenteral (LVP) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2019-2024) & (M Units)
    Table 47. Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2025-2030) & (M Units)
    Table 48. Middle East & Africa Large Volume Parenteral (LVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Large Volume Parenteral (LVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2019-2024)
    Table 51. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2025-2030)
    Table 52. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2019-2024)
    Table 53. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2025-2030)
    Table 54. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2019-2024)
    Table 57. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2025-2030)
    Table 58. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2019-2024)
    Table 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2025-2030)
    Table 60. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2019-2024)
    Table 61. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2025-2030)
    Table 62. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2019-2024)
    Table 63. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2025-2030)
    Table 64. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2019-2024)
    Table 67. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2025-2030)
    Table 68. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2019-2024)
    Table 69. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2025-2030)
    Table 70. Baxter Healthcare Corporation Information
    Table 71. Baxter Healthcare Description and Business Overview
    Table 72. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 73. Baxter Healthcare Large Volume Parenteral (LVP) Product
    Table 74. Baxter Healthcare Recent Developments/Updates
    Table 75. Kelun Pharma Corporation Information
    Table 76. Kelun Pharma Description and Business Overview
    Table 77. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 78. Kelun Pharma Large Volume Parenteral (LVP) Product
    Table 79. Kelun Pharma Recent Developments/Updates
    Table 80. B. Braun Corporation Information
    Table 81. B. Braun Description and Business Overview
    Table 82. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 83. B. Braun Large Volume Parenteral (LVP) Product
    Table 84. B. Braun Recent Developments/Updates
    Table 85. Fresenius Corporation Information
    Table 86. Fresenius Description and Business Overview
    Table 87. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 88. Fresenius Large Volume Parenteral (LVP) Product
    Table 89. Fresenius Recent Developments/Updates
    Table 90. Teva Pharmaceutical Industries Corporation Information
    Table 91. Teva Pharmaceutical Industries Description and Business Overview
    Table 92. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 93. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
    Table 94. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 95. Pfizer (Hospira) Corporation Information
    Table 96. Pfizer (Hospira) Description and Business Overview
    Table 97. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 98. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
    Table 99. Pfizer (Hospira) Recent Developments/Updates
    Table 100. Ostuka Pharmaceutical Corporation Information
    Table 101. Ostuka Pharmaceutical Description and Business Overview
    Table 102. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 103. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
    Table 104. Ostuka Pharmaceutical Recent Developments/Updates
    Table 105. CR Double-Crane Corporation Information
    Table 106. CR Double-Crane Description and Business Overview
    Table 107. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 108. CR Double-Crane Large Volume Parenteral (LVP) Product
    Table 109. CR Double-Crane Recent Developments/Updates
    Table 110. Pisa Corporation Information
    Table 111. Pisa Description and Business Overview
    Table 112. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 113. Pisa Large Volume Parenteral (LVP) Product
    Table 114. Pisa Recent Developments/Updates
    Table 115. Huaren Corporation Information
    Table 116. Huaren Description and Business Overview
    Table 117. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 118. Huaren Large Volume Parenteral (LVP) Product
    Table 119. Huaren Recent Developments/Updates
    Table 120. Patheon Corporation Information
    Table 121. Patheon Description and Business Overview
    Table 122. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 123. Patheon Large Volume Parenteral (LVP) Product
    Table 124. Patheon Recent Developments/Updates
    Table 125. Beximco Pharma Corporation Information
    Table 126. Beximco Pharma Description and Business Overview
    Table 127. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 128. Beximco Pharma Large Volume Parenteral (LVP) Product
    Table 129. Beximco Pharma Recent Developments/Updates
    Table 130. Albert David Corporation Information
    Table 131. Albert David Description and Business Overview
    Table 132. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 133. Albert David Large Volume Parenteral (LVP) Product
    Table 134. Albert David Recent Developments/Updates
    Table 135. PSI Ltd Corporation Information
    Table 136. PSI Ltd Description and Business Overview
    Table 137. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 138. PSI Ltd Large Volume Parenteral (LVP) Product
    Table 139. PSI Ltd Recent Developments/Updates
    Table 140. Ozon Pharmaceuticals Corporation Information
    Table 141. Ozon Pharmaceuticals Description and Business Overview
    Table 142. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 143. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
    Table 144. Ozon Pharmaceuticals Recent Developments/Updates
    Table 145. BAG Healthcare Corporation Information
    Table 146. BAG Healthcare Description and Business Overview
    Table 147. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 148. BAG Healthcare Large Volume Parenteral (LVP) Product
    Table 149. BAG Healthcare Recent Developments/Updates
    Table 150. BML Parenteral Drugs Corporation Information
    Table 151. BML Parenteral Drugs Description and Business Overview
    Table 152. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 153. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
    Table 154. BML Parenteral Drugs Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Large Volume Parenteral (LVP) Distributors List
    Table 158. Large Volume Parenteral (LVP) Customers List
    Table 159. Large Volume Parenteral (LVP) Market Trends
    Table 160. Large Volume Parenteral (LVP) Market Drivers
    Table 161. Large Volume Parenteral (LVP) Market Challenges
    Table 162. Large Volume Parenteral (LVP) Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Large Volume Parenteral (LVP)
    Figure 2. Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Large Volume Parenteral (LVP) Market Share by Type in 2023 & 2030
    Figure 4. Soft Bag LVP Product Picture
    Figure 5. Plastic Bottle LVP Product Picture
    Figure 6. Glass Bottle LVP Product Picture
    Figure 7. Global Large Volume Parenteral (LVP) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Large Volume Parenteral (LVP) Market Share by Application in 2023 & 2030
    Figure 9. Basic Infusion
    Figure 10. Therapeutic Infusion
    Figure 11. Nutritious Infusion
    Figure 12. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Large Volume Parenteral (LVP) Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Large Volume Parenteral (LVP) Sales (2019-2030) & (M Units)
    Figure 15. Global Large Volume Parenteral (LVP) Average Price (US$/K Units) & (2019-2030)
    Figure 16. Large Volume Parenteral (LVP) Report Years Considered
    Figure 17. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2023
    Figure 18. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Large Volume Parenteral (LVP) Players: Market Share by Revenue in 2023
    Figure 20. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2019-2030)
    Figure 23. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2019-2030)
    Figure 27. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2019-2030)
    Figure 35. China Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Large Volume Parenteral (LVP) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Large Volume Parenteral (LVP) by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Large Volume Parenteral (LVP) by Type (2019-2030)
    Figure 56. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Large Volume Parenteral (LVP) by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Large Volume Parenteral (LVP) by Application (2019-2030)
    Figure 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2019-2030)
    Figure 60. Large Volume Parenteral (LVP) Value Chain
    Figure 61. Large Volume Parenteral (LVP) Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions